Cargando…
CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity
Charcot-Marie-Tooth (CMT) constitutes a group of heterogeneous hereditary motor and sensor neuropathies. Mutations in mitofusin-2 (MFN2) cause CMT type 2A by altering mitochondrial fusion and trafficking along with the axonal microtubule system. In literature patients presenting with CMT2A are repor...
Autores principales: | Guerriero, Silvana, D’Oria, Francesco, Rossetti, Giacomo, Favale, Rosa Anna, Zoccolella, Stefano, Alessio, Giovanni, Petruzzella, Vittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039061/ https://www.ncbi.nlm.nih.gov/pubmed/32110117 http://dx.doi.org/10.2147/IMCRJ.S237620 |
Ejemplares similares
-
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A
por: Franco, Antonietta, et al.
Publicado: (2020) -
Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2A
por: Dorn, Gerald W.
Publicado: (2021) -
Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset
por: Li, Yu-Jie, et al.
Publicado: (2019) -
Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation
por: Zanfardino, Paola, et al.
Publicado: (2022) -
Leber’s hereditary optic neuropathy, intellectual disability and epilepsy presenting with variable penetrance associated to the m.3460G >A mutation and a heteroplasmic expansion of the microsatellite in MTRNR1 gene – case report
por: Bianco, Angelica, et al.
Publicado: (2018)